Delays in Starting Tuberculosis Treatment in Norway
Author Information
Author(s): Farah Mohamed Guled, Rygh Jens Henning, Steen Tore W, Selmer Randi, Heldal Einar, Bjune Gunnar
Primary Institution: Norwegian Institute of Public Health, Oslo, Norway
Hypothesis
What are the delays in the start of treatment for tuberculosis patients in the Oslo/Akershus region of Norway and what are the risk factors for these delays?
Conclusion
A high proportion of patients had total delays in start of TB treatment exceeding two months, highlighting the need for increased awareness of TB among the general population and health personnel.
Supporting Evidence
- The median total delay for all patients was 63 days, with significant delays noted for extra-pulmonary TB cases.
- Health care system delays were longer for patients born in Norway compared to those born abroad.
- 86% of the patients were foreign-born, indicating a high prevalence of TB among immigrants.
Takeaway
This study found that many people with tuberculosis in Norway wait too long to start treatment, which can make them sicker and spread the disease to others.
Methodology
The study analyzed data from the National TB Registry and clinical case notes, assessing delays in treatment and their association with various factors using multiple linear regression.
Potential Biases
Potential biases include incomplete data on delays and the focus on delays in Norway only for some foreign-born patients.
Limitations
Primary health care and hospital notes were often incomplete regarding delays, especially for patient delay, which may have affected the results.
Participant Demographics
Of the 83 patients, 71 (86%) were born abroad, with a median age of 32 years; 57 were pulmonary cases and 26 were extra-pulmonary cases.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website